Fueling Curiosity: MilliporeSigma’s Mobile Lab is Inspiring the Next Generation of Scientists
Fueling Curiosity: MilliporeSigma’s Mobile Lab is Inspiring the Next Generation of Scientists
MilliporeSigma’s Curiosity Cube Rolls Into Maryland, Bringing Hands-on Learning Opps to Local Students
MilliporeSigma’s Curiosity Cube Rolls Into Maryland, Bringing Hands-on Learning Opps to Local Students By Alex Keown and Sarah EllinwoodMay 9, 2023 If you’re a scientist, chances are growing up you [….]
5 Questions With Jennifer Chiang, Head of People Strategy Execution at MilliporeSigma
During the pandemic, I think many people went through a lot of self-reflection—including myself! Through personal health experiences, and also participating in a COVID-19 vaccine trial, I realized how important to me it was to serve a mission related to healthcare and science. It’s a field that ultimately saves lives – and with that I landed here at MilliporeSigma, a biotechnology company at Rockville, MD. I am currently the Head of People Strategy Execution for our Rockville site, which in short, I like to describe as “people harmony.” My work includes recruiting, community partnerships, employee engagement, DE&I, and leadership development.
MilliporeSigma invests $286M in new Montgomery County facility
International biosciences company MilliporeSigma is adding 500 new jobs to the Montgomery County region with its upcoming expansion project.
The company, known locally as BioReliance Corporation, is moving into a new 250,000 square-foot space at the Traville Gateway campus in Rockville, where it will retain at least 600 existing workers and add the new full-time positions. The company credits expanding its biosafety testing capacity in the Mid Atlantic due to Montgomery County’s ideal East Coast location and accessibility to Maryland’s highly trained and technical workforce.
MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced the acquisition of MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. The MAST® platform was developed in Bend, Oregon. The financial details of the deal were not disclosed.
5 Questions With Jaime Ownby, Federal Government Market Development Manager at MilliporeSigma
Jaime is a Teacher turned Research Sales Rep turned Market Development Manager. She received her degree in Chemistry from Trinity Washington University, in DC. After graduation, she became a Chemistry Teacher, at the same high school that she graduated from. A few months before the pandemic, she changed careers and became a field sales rep at the NIH for the life science company, MilliporeSigma.